AR and prostate carcinoma: Taken together, our results support that AR could inhibit some metastasis-promoting pathways or molecules in prostate cancer, and suggest that knockdown of DANCR could lessen the side effect of AR inhibitor, which may be useful in the treatment of prostate cancer.